SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biomatrix (BXM) Looking Great

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: John McCarthy who wrote (282)12/13/1997 5:26:00 PM
From: John McCarthy  Read Replies (1) of 569
 
Some pretty harsh NSAIDs numbers ....

Overprescription of non-steroidal anti-inflammatory drugs

A recent study examined cases in which physicians were thought to overprescribe non-steroidal anti-inflammatory drugs (NSAIDs) for the treatment of arthritis in elderly patients.

- experts say use of the drugs by elderly persons
results in increased risk of stomach bleeding and ulcers,
and note that the drugs are linked to an
estimated 7,600 deaths and 76,000 hospitalizations
in the U.S. every year.

- elderly persons with peptic-ulcer disease and
high blood pressure are known to be at up to six-times the
risk of NSAID-related complications than others.

- Canadian researchers found that of 57 cases in which
NSAIDs were prescribed for osteoarthritis, only 19
cases involved assessment of risk factors for the drugs.

- according to the American College of Rheumatology, NSAIDs should only be prescribed when other treatments have failed.

- the study is in the Annals of Internal Medicine (1997;127:429-438).

mediconsult.com

Regards,

John
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext